Results 21 to 30 of about 51,838 (261)

Chronic Migraine as a Primary Chronic Pain Syndrome and Recommended Prophylactic Therapeutic Options: A Literature Review

open access: yesLife, 2023
Chronic pain conditions have a high socio-economic impact and represent a burden for patients, and their management is a challenge for healthcare professionals.
Délia Szok   +3 more
doaj   +1 more source

Exercise in Treatment of Migraine Including Chronic Migraine

open access: yesCurrent Pain and Headache Reports, 2021
With this review, we aimed to investigate the effect of exercise on migraine and explored the possibility of exercise as a treatment option for migraine.A close association of physical activity and exercise with migraine has been reported in clinical and population-based studies.
Tae-Jin Song, Min Kyung Chu
openaire   +3 more sources

Chronic migraine and optical higher-order aberrations: Is there a relationship between them?

open access: yesDelta Journal of Ophthalmology, 2019
Introduction Migraine is a neurological disorder with a wide spectrum of manifestations, including ocular manifestations. The present study aimed to investigate the relationship between chronic migraine and optical higher-order aberrations.
Ahmed A Alhagaa
doaj   +1 more source

Aberrant cerebral blood flow in tinnitus patients with migraine: a perfusion functional MRI study

open access: yesThe Journal of Headache and Pain, 2021
Purpose Migraine is often accompanied with chronic tinnitus that will affect the cerebral blood flow (CBF) and exacerbate the tinnitus distress. However, the potential relationship between migraine and tinnitus remains unclear.
Zhen-Gui Xu   +5 more
doaj   +1 more source

A study of cardiovascular reflex tests in adults with chronic migraine and chronic tension-type headache

open access: yesAsian Journal of Medical Sciences, 2023
Background: Autonomic function tests can be used by patients with chronic migraine and chronic tension-type headaches (TTH) as a non-invasive, sensitive, and reliable marker for evaluating heart function.
Waqas Alauddin   +4 more
doaj   +1 more source

Periaqueductal gray matter echogenicity as a marker of migraine chronification: a case control study

open access: yesThe Journal of Headache and Pain, 2023
Background Migraine is one of the most prevalent and disabling medical diseases in the world. The periaqueductal gray matter and the red nucleus play an important role in its pathogenesis.
Dolores Vilas   +8 more
doaj   +1 more source

Chronic Migraine, Comorbidity, and Socioeconomic Deprivation: Cross-Sectional Analysis of a Large Nationally Representative Primary Care Database

open access: yesJournal of Comorbidity, 2017
Background: Chronic migraine is common but there is limited knowledge on associated comorbidities. Objectives: To examine mental and physical comorbidities in chronic migraine and the influence of socioeconomic status in a large, nationally ...
Gary McLean, Stewart W. Mercer
doaj   +1 more source

‘Chronic migraine’ is a misnomer

open access: yesNeurología (English Edition), 2017
las lesiones son extensas o la sintomatología es muy intensase prefiere tratamiento quirúrgico8. En el caso de nuestrapaciente, el tratamiento con amitriptilina y diversos fárma-cos neuromoduladores solamente redujo de forma parcial lasintomatología junto con la presencia de efectos adversosque limitaban la eficacia de los fármacos.
openaire   +3 more sources

Paramagnetic Rim Lesions Are Associated With Trans‐Synaptic Degeneration of the Visual Pathway in Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem   +17 more
wiley   +1 more source

Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine

open access: yesThe Journal of Headache and Pain, 2021
Background Galcanezumab, a humanized monoclonal antibody that binds calcitonin gene-related peptide, has demonstrated a significant reduction in monthly migraine headache days compared with placebo. Here, we analyze data from 3 randomized clinical trials
Michael Ament   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy